GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development

Pharmaceuticals company is investing £400m in UK life sciences and moving scientists to new Cambridge R&D site Business live – latest updates The British drugmaker GSK is to announce sweeping job cuts as part of a £1.9bn cost-cutting programme to pay for a £400m investment in UK life sciences over the next three years, including in a new research and development centre in Cambridge, as it looks to develop drugs more quickly under its new chief executive. The pharmaceuticals company announced…